The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 17, 2018
Filed:
Sep. 05, 2014
Applicant:
Taiho Pharmaceutical Co., Ltd., Chiyoda-ku, JP;
Inventor:
Hiroyuki Okabe, Hanno, JP;
Assignee:
TAIHO PHARMACEUTICAL CO., LTD., Chiyoda-ku, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/7072 (2006.01); A61K 31/513 (2006.01); C07K 16/22 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7072 (2013.01); A61K 31/513 (2013.01); A61K 39/395 (2013.01); A61K 39/39533 (2013.01); C07K 16/22 (2013.01); C07K 16/2863 (2013.01); A61K 2039/505 (2013.01);
Abstract
Provided is a novel method for treating a cancer using an FTD/TPI combination drug, which shows remarkably excellent antitumor effect and small adverse effects. An antitumor agent, in which a combination drug containing trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5 and an anti-VEGF antibody or anti-EGFR antibody are administered in combination.